Anesthesia And Respiratory Devices Market: Current Analysis and Forecast (2021-2027)
Anesthesia and Respiratory Devices Market is anticipated display significant CAGR of 7% over the forecast period (2021-2027). The growth of the global anesthesia and respiratory devices market can be mainly attributed due to the rise in respiratory illnesses such as COPD, and OSA coupled with the surge in awareness programs for anesthesia and respiratory devices & management and the increasing geriatric population, thus contributing significantly to the growth of the market. According to the World Health Organization (WHO), every year about 65 million people suffer from COPD, 334 million people suffer from asthma and over 10 million people develop tuberculosis (TB) globally. Furthermore, the rising number of tobacco smokers will upsurge anesthesia and respiratory devices market size over the forecast timeframe. Smoking causes about 90% of all lung cancer deaths and thus smokers are more likely to die from COPD than non-smokers.
Some of the major players operating in the market include SunMed, Smiths Group plc, ResMed, Masimo, Koninklijke Philips N.V., Invacare Corporation, Teleflex Incorporated, Hamilton Medical, GE Healthcare, Fisher & Paykel Healthcare Limited.
The ongoing COVID-19 pandemic across the world have had a tremendous impact on different spectra of society, the market for anesthesia and respiratory devices is no less impacted by this. In the early phase of the pandemic, due to the increasing cases of COVID-19, all hospitals, globally, had canceled their scheduled and elective surgeries. Acute surgical emergencies were still inevitable and were being addressed in a timely and sensible manner. According to the report published by the British Journal of Surgery, in May 2020, an estimated 585,000 elective surgeries were postponed in the 12-week lockdown in India alone, and 28.4 million elective surgeries worldwide are expected to be canceled or postponed. Thus, the halt of surgical procedures is the major factor that is likely to hamper the usage of anesthesia and respiratory devices.
Insights Presented in the Report
"Amongst Product Type, Respiratory Devices segment dominated the market in 2020”
Based on product type, the market is bifurcated into anesthesia devices and respiratory devices. Amongst them, anesthesia devices is further categorized into anesthesia machines, monitors, and anesthetic information management systems. In addition, respiratory devices is further bifurcated into respiratory equipment, respiratory disposables, and respiratory measurement devices. Technological advancements in respiratory devices further offer segment growth opportunities. Additionally, the rising geriatric population that is prone to various respiratory conditions, increasing healthcare expenditure, and emerging market economies will offer growth potential for respiratory devices in the forthcoming period.
"Amongst End User, Diagnostic Centers category to witness fastest growth rate”
Based on end user, the market is bifurcated into hospitals, clinics, homecare settings, ambulatory surgical centers, and others. Among them, the hospital segment held the largest market share in 2020 and is further projected to maintain its leading position in the market during the forecast period. This is mainly due to the rising adoption of anesthesia and respiratory devices in healthcare settings coupled with growing investments by government and private healthcare facilities to update infrastructure and devices. Due to rising chronic diseases, healthcare facilities focus on providing better diagnoses and treatment of these diseases. As per the Pan American Health Organization, 75% of all hospitalized patients require supplemental oxygen treatment. Furthermore, the high demand for therapeutic devices for homecare settings and the launch of homecare devices by key players is also expected to provide lucrative growth opportunities for the market. For instance, In January 2019, Masimo received the FDA approval for MightSat Rx finger pulse oximeter that can be used at home. According to the Agency for Healthcare Research and Quality (AHRQ), in 2014, 17.2 million hospital visits resulted into at least one surgery.
"North America will Dominate the Market During the Forecast Period”
For a better understanding of the demand of Anesthesia and Respiratory Devices Market, the market is analyzed for major regions including North America (US, Canada, Rest of North America); Europe (Germany, UK, France, Italy, Rest of Europe); Asia-Pacific (China, India, Japan, Australia, Rest of Asia-Pacific); and Rest of World. Currently, North America dominated the market in 2020. In North America, the enlarged availability of anesthesia and respiratory devices in hospitals coupled with an increased incidence of respiratory disorders and lifestyle-related diseases, are driving this market’s development in the region. For instance, according to the Centers for Disease Control and Prevention (CDC), about 40 million adults in the U.S., and about 4.7 million middle and early adolescence age individuals smoke at least one tobacco product every day, including e-cigarettes. Thus, the rising geriatric population, chronic diseases, and the number of surgeries with higher adoption and wide accessibility of advanced anesthesia and respiratory devices in the region is expected to drive the North American anesthesia and respiratory devices market.
Reasons to buy this report:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook